Denmark vs Small island developing States (SIDS): Proportion of the target population who received the final dose of
Denmark
81.0%
in 2024
Small island developing States (SIDS)
22.0%
in 2024
Denmark rank
22nd
Small island developing States (SIDS) rank
25th
Proportion of the target population who received the final dose of over time
- Denmark
- Small island developing States (SIDS)
How they compare
Denmark currently reports 81.0% against 22.0% in Small island developing States (SIDS), a difference of 59.0%.
That makes Denmark's figure about 3.7 times Small island developing States (SIDS)'s.
Across all 14 years both countries report, Denmark has been ahead every year.
Denmark ranks 22nd and Small island developing States (SIDS) ranks 25th of 107 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.0% | 4.0% | 52.0% | Denmark |
| 2020s | 80.6% | 13.2% | 67.4% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Denmark or Small island developing States (SIDS)?
- Denmark, at 81.0% against 22.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Denmark and Small island developing States (SIDS)?
- 59.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Small island developing States (SIDS)?
- 14 years are reported by both, from 2011 to 2024.
- How do Denmark and Small island developing States (SIDS) rank globally for proportion of the target population who received the final dose of?
- Denmark ranks 22nd and Small island developing States (SIDS) ranks 25th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.